Order Article Reprints

Young P, Elghawy O, Mock J, Wynter E, Gentzler RD, Martin LW, Novicoff W, Hall R. Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current Oncology. 2024; 31(1):260-273. https://doi.org/10.3390/curroncol31010017

Young, Philip, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D. Gentzler, Linda W. Martin, Wendy Novicoff, and Richard Hall. 2024. "Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors" Current Oncology 31, no. 1: 260-273. https://doi.org/10.3390/curroncol31010017

Young, P., Elghawy, O., Mock, J., Wynter, E., Gentzler, R. D., Martin, L. W., Novicoff, W., & Hall, R. (2024). Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(1), 260-273. https://doi.org/10.3390/curroncol31010017